Skip to main content

Table 2 Comparison between hamartoma and carcinoid tumors

From: Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas

Population characteristics

Hamartoma n = 38

Carcinoid tumor n = 89

p-value

Age (years)

58 [49–67]

60 [45–68]

p = 0.93

Gender

   

 Male

21 (55%)

18 (20%)

p = 0.01

 Female

17 (45%)

71 (80%)

 

Type of surgery

   

 Pneumonectomy

0 (0%)

4 (4%)

p = 0.01

 Lobectomy

8 (21%)

68 (76%)

 

 Segmentectomy

0 (0%)

10 (11%)

 

 Wedge resection

22 (58%)

7 (9%)

 

 Enucleation

7 (18%)

0 (0%)

 

 Biopsy

1 (3%)

0 (0%)

 

Diameter (mm)

14 [10–24]

18 [12–26]

p = 0.03

Calcifications

11 (44%)

11 (18%)

p = 0.02

Anatomic location

   

 Central

10 (26%)

46 (52%)

p = 0.01

 Peripheral

28 (74%)

43 (48%)

 

Bronchial contact

10 (26%)

63 (71%)

p = 0.01

Endobronchial protrusion

4 (11%)

39 (44%)

p = 0.01

Atelectasis

2 (5%)

28 (31%)

p = 0.01

Borders shape

   

 Smooth

22 (58%)

59 (66%)

p = 0.37

 Lobulated

16 (42%)

30 (34%)

 

Mean 2DROI value (HU)

28 [17–36]

79 [55–105]

p = 0.01

  1. Demographic and clinical data. Results were expressed in median [Q1-Q3] for quantitative data or number (percentage) for qualitative data. ‘n = ’ corresponds to the number of patients operated. HU—Hounsfield units. A p-value lower than 0.05 was considered as significant. p-value < 0.05 was highlighted in bold